But we struggle to commercialize our biotech.
We should look to Europe—where public investment helps homegrown IP scale into global companies.
www.theglobeandmail.com/business/com...
But we struggle to commercialize our biotech.
We should look to Europe—where public investment helps homegrown IP scale into global companies.
www.theglobeandmail.com/business/com...